Company: PBH
Filing Date: 2025-05-09
Form Type: 10-K
Source: 0001295947-25-000017
Chunk: 96

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-05-09
Form: 10-K
Item: Item 8
Chunk 96
---
 lease liabilities(7,630)(7,134)(6,687)Other(898)(1,412)(275)Net cash provided by operating activities251,515 248,926 229,716 Investing Activities   Purchases of property, plant and equipment(8,224)(9,550)(7,784)Acquisitions and other(9,228)(10,561)(3,800)Net cash used in investing activities(17,452)(20,111)(11,584)Financing Activities   Term Loan repayments(135,000)(225,000)(135,000)Borrowings under revolving credit agreement— — 20,000 Repayments under revolving credit agreement— — (20,000)Payment of debt costs— (769)— Payments of finance leases(4,536)(2,827)(2,752)Proceeds from exercise of stock options14,802 18,089 7,372 Fair value of shares surrendered as payment of tax withholding(5,832)(5,508)(5,466)Repurchase of common stock(51,509)(25,000)(50,000)Net cash used in financing activities(182,075)(241,015)(185,846)Effects of exchange rate changes on cash and cash equivalents(573)180 (982)Increase (decrease) in cash and cash equivalents51,415 (12,020)31,304 Cash and cash equivalents - beginning of year46,469 58,489 27,185 Cash and cash equivalents - end of year$97,884 $46,469 $58,489 Interest paid$47,804 $63,248 $54,243 Income taxes paid$52,117 $59,637 $40,739 

See accompanying notes.

51

Prestige Consumer Healthcare Inc.

Notes to Consolidated Financial Statements

 1.    Business and Basis of Presentation

Nature of BusinessPrestige Consumer Healthcare Inc. (referred to herein as the “Company” or “we”, which reference shall, unless the context requires otherwise, be deemed to refer to Prestige Consumer Healthcare Inc. and all of its direct and indirect 100% owned subsidiaries on a consolidated basis) is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (“OTC”) healthcare products to mass merchandisers, drug, food, dollar, convenience